Dr. Ellen Langemeijer

This page has been moved. You are being redirected.

+31 20 59 87540
faculteit der bètawetenschappen ( moleculaire en computationele toxicologie )
Managing director

Dr. Ellen Langemeijer studied Molecular and Cellular Biology at VU University Amsterdam, where she graduated in 1998. Upon graduation, she worked for six years at Galapagos Genomics as a scientist on diverse research projects, including the development of the patented adenoviral SilenceSelect knock-down library. 

Langemeijer returned to VU University in 2005 and started her PhD research at the Medicinal Chemistry research group. Supervised by Prof. Martine Smit, she worked on oncomodulatory signaling, by two herpesvirus-encoded G protein-coupled receptors (GPCRs), US28 and UL33. Subsequently, she was a post-doctoral researcher in the group of Prof. Ad IJzerman at Leiden University, studying functional selectivity of ligands for the adenosine receptors, also GPCRs.

Early 2013, Langemeijer returned to the Department of Chemistry and Pharmaceutical Sciences at VU University, joining the managing entity of SafeSciMET; an European Modular Education and Training Programme in Safety Sciences for Medicines. In July 2013, Langemeijer also became managing director of the Amsterdam Institute for Molecules, Medicines and Systems.